ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2020 American Transplant Congress

    Effect of Intravenous Ferric Gluconate on Post Heart Transplant Outcomes in Patients Bridged with Left Ventricular Assist Devices

    N. Krepostman, D. Kim, D. Masic, S. Kuhrau, J. Negrelli, M. Liebo, E. Raichlin, A. Heroux, H. Basha

    Internal Medicine, Loyola University Medical Center, Maywood, IL

    *Purpose: Our study examined the effect of intravenous (IV) ferric gluconate compared to oral iron repletion in reducing 30-day hospital readmissions and all-cause mortality in…
  • 2020 American Transplant Congress

    The Prevalence of Preemptive Transplantation at a Large Volume Kidney Transplant Center

    T. Menser1, M. J. Hobeika2, S. G. Yi2, T. Nisar1, A. Gaber2

    1Houston Methodist Research Institute, Houston, TX, 2Houston Methodist Hospital, Houston, TX

    *Purpose: In the wake of the Executive Order on Advancing American Kidney Health, it is essential to fully examine the current care paradigm for chronic…
  • 2020 American Transplant Congress

    Lowering Meld, Diminishing Length of Stay, and Increasing Liver Transplant Numbers Comes Through the Generosity of Others: Declined HCV-NAT Offers Subsequently Transplanted Have Excellent Outcomes

    R. Gilroy, S. Sell, J. Krong, A. Gagnon, I. Zendejas, S. Fujita, M. Rodriguez, D. Alonso

    Transplant Services, Intermountain Healthcare, Murray, UT

    *Purpose: There is variability between programs in the acceptance of organ offers. This paper examines offer, acceptance and program performance with HCV NAT positive donor…
  • 2020 American Transplant Congress

    Racial Disparities in Long-Term Outcomes in Kidney Transplantation from Elderly Donors in United States

    S. Shah, B. Abu Jawdeh, S. Bumb, T. Kaur, M. Anand, A. Govil, R. Jain

    University of Cincinnati, Cincinnati, OH

    *Purpose: Kidney transplantation offers survival benefit and improved quality of life in end-stage renal disease patients. Because the waiting list continues to grow, there has…
  • 2020 American Transplant Congress

    T and B Lymphocyte Dynamics after Genetically-Modified Pig-To-Baboon Kidney Xenotransplantation with an Anti-CD40mAb-Based Immunosuppressive Regimen

    A. Jagdale1, H. Iwase1, H. Nguyen1, T. Yamamoto1, D. Ayares2, D. Anderson1, D. Eckhoff1, D. Cooper1, H. Hara1

    1Surgery, University of Alabama at birmingham, Birmingham, AL, 2Revivicor, Blacksburg, VA, VA

    *Purpose: We have evaluated recovery of T and B lymphocytes and their subsets after depletion by anti-thymocyte globulin (ATG) and an anti-CD20mAb (Rituximab), followed by…
  • 2020 American Transplant Congress

    TRANSFORM Study (NCT01950819): Application of the Ibox Clinical Trial Simulation Tool to Project Long-Term Kidney Allograft Outcome

    G. Divard1, O. Aubert1, M. Raynaud1, J. Pascual2, F. Vincenti3, P. Bernhardt4, C. Legendre1, A. Loupy1, .. on behalf of TRANSFORM Investigators5

    1INSERM U970, Paris Transplant Group, Paris, France, 2Department of Nephrology, Hospital del Mar/Universitat Autònoma de Barcelona, Barcelona, Spain, 3Department of Surgery/Kidney Transplant Service, University of California, San Francisco, CA, 4Research and Development, Novartis Pharma AG, Basel, Switzerland, 5TRANSFORM Investigators, Basel, Switzerland

    *Purpose: The development of pharmaceutical agents in transplantation is currently limited by long waits for hard endpoints. We sought to use a risk stratification system…
  • 2020 American Transplant Congress

    Recipient and Donor Factors Associated with Post-Donation ESRD in Related White Living Kidney Donors

    J. Wainright1, A. Robinson1, A. Wilk1, D. Klassen2, W. Cherikh1, L. Cartwright1, D. Stewart1

    1Research, UNOS, Richmond, VA, 2Chief Medical Officer, UNOS, Richmond, VA

    *Purpose: We studied post-donation ESRD in white first-degree related living kidney donors (RLKDs) in the US between 1994 and 2018 (n=45700); this study is the…
  • 2020 American Transplant Congress

    Simultaneous Heart Kidney Transplant Benefits are Concentrated in the Dialysis Dependent Population

    B. I. Shaw1, M. L. Samoylova1, Z. W. Fitch1, M. Bishawi1, R. Schmitz1, S. J. Kesseli1, A. S. Barbas1, C. B. Patel2, S. L. Sanoff2, L. M. McElroy1

    1Surgery, Duke University, Durham, NC, 2Medicine, Duke University, Durham, NC

    *Purpose: With ongoing growth of simultaneous organ transplant and increased attention to allocation policy, we examined trends in simultaneous heart-kidney (SHK) transplantation outcomes over the…
  • 2020 American Transplant Congress

    Pilot Donor App Users Maintain Higher Transplant Rates Than Matched Controls

    L. R. Herbst, A. D. Love, P. Chiang, K. Kumar, B. King, A. Massie, J. Garonzik Wang, D. L. Segev, A. M. Cameron

    Johns Hopkins University, Baltimore, MD

    *Purpose: We previously conducted a pilot study demonstrating that patients who used the Donor App (DA) were 6.6 times more likely to generate a live…
  • 2020 American Transplant Congress

    Liver Transplantation of Donors and Recipients’ with Situs Inversus Totalis: Case Reports and Literature Review

    L. Del Angel Diaz, A. Simioni, G. D'Amico, Q. Liu, K. Hashimoto, M. Fujiki, B. Eghtesad, F. Aucejo, K. Sasaki, C. Kwon, C. Miller, C. Quintini, T. Diago-Uso

    Cleveland Clinic, Cleveland, OH

    *Purpose: Situs Inversus Totalis (SIT) is a rare condition affecting 0.1% of the general population. It was historically a contraindication for LTx and graft donation.…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences